{
  "id": 7298396,
  "title": "The Gulf’s GLP-1 boom has yet to move the needle on obesity",
  "url": "https://urgent.news/2026/09/14/the-gulfs-glp-1-boom-has-yet-to-move-the-needle-on-obesity",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-14T10:14:50.000Z",
  "source": {
    "name": "Arabian Business",
    "slug": "arabian-business",
    "url": "https://www.arabianbusiness.com/business/healthcare/gulf-glp-1-boom-obesity"
  },
  "original_language": "en",
  "account": null,
  "summary": "Novo Nordisk says demand is rising across the Gulf but there is not enough evidence to prove the drugs are reducing obesity rates, while Eli Lilly says most people who could benefit still do not receive them",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}